NRTI-Associated Mitochondrial Toxicity
Some of the toxicity associated with antiretroviral therapy appears to be linked to the use of NRTIs and bears a notable resemblance to genetically based mitochondrial diseases. Given this similarity, could acquired mitochondrial dysfunction -- either caused or accelerated by NRTI use -- account for such seemingly unrelated antiretroviral toxicities as neuropathy, myopathy, hepatic steatosis, lactic acidosis, bone marrow suppression, and fat atrophy? In this review, we will explore the scientific basis for NRTI-related mitochondrial toxicity, its clinical manifestations, and proposed therapies.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)
